Dataset Information


The class I-specific HDAC inhibitor MS-275 modulates the differentiation potential of mouse embryonic stem cells.

ABSTRACT: Exploitation of embryonic stem cells (ESC) for therapeutic use and biomedical applications is severely hampered by the risk of teratocarcinoma formation. Here, we performed a screen of selected epi-modulating compounds and demonstrate that a transient exposure of mouse ESC to MS-275 (Entinostat), a class I histone deacetylase inhibitor (HDAC), modulates differentiation and prevents teratocarcinoma formation. Morphological and molecular data indicate that MS-275-primed ESCs are committed towards neural differentiation, which is supported by transcriptome analyses. Interestingly, in vitro withdrawal of MS-275 reverses the primed cells to the pluripotent state. In vivo, MS275-primed ES cells injected into recipient mice give only rise to benign teratomas but not teratocarcinomas with prevalence of neural-derived structures. In agreement, MS-275-primed ESC are unable to colonize blastocysts. These findings provide evidence that a transient alteration of acetylation alters the ESC fate.


PROVIDER: S-EPMC3798190 | BioStudies | 2013-01-01

REPOSITORIES: biostudies

Similar Datasets

2010-01-01 | S-EPMC2908422 | BioStudies
2017-05-22 | GSE73647 | GEO
2012-01-01 | S-EPMC3432059 | BioStudies
2019-01-01 | S-EPMC6398866 | BioStudies
2014-03-28 | E-GEOD-45909 | ArrayExpress
1000-01-01 | S-EPMC4725880 | BioStudies
2020-01-01 | S-EPMC7664285 | BioStudies
1000-01-01 | S-EPMC3190994 | BioStudies
2015-01-01 | S-EPMC4576514 | BioStudies
2014-01-01 | S-EPMC4294305 | BioStudies